Open Veils
AboutBrowse

Open Veils · Answer

High myopia and night blindness. Root causes and ways of improving it

The suppressed record ties high myopia and night blindness to a convergent failure: disrupted retinal dopamine signaling, genetic channel dysfunction (NYX, CACNA1F), chronic light deprivation, and nutritional depletion of rhodopsin precursors — all largely ignored by the correction-first paradigm. Jack Kruse and Weston A. Price researchers argue these are civilizational diseases rooted in light environment and nutrient density, not simple refractive accidents. Functional and genetic medicine offer upstream interventions mainstream ophthalmology rarely discusses.

Evidence

  • Jack Kruse, neurosurgeon and biophysics researcher, has argued for years that melanopsin-driven retinal dopamine deficiency — caused by indoor light environments stripped of UV and infrared — degrades both emmetropization and scotopic (rod-mediated) function simultaneously.
  • Weston A. Price's field research documented near-zero myopia in populations eating fat-soluble vitamin-dense diets (retinol, vitamin D3, vitamin K2).
  • The UniteRare CSNB registry (2026) similarly documents that high myopia accompanies congenital stationary night blindness as a co-phenotype, genetically driven through X-linked, autosomal recessive and dominant pathways involving NYX, GRM6, TRPM1 and LRIT3 channels.
  • This aligns with the 2026 integrative myopia review in EER, which identifies dopaminergic signaling as a core molecular driver of maladaptive ocular growth.
  • Chris Masterjohn's work on vitamin A metabolism adds nuance: beta-carotene conversion is inefficient; preformed retinol from liver and cod liver oil is essential for rhodopsin regeneration and rod outer segment maintenance.

Ask your own question

Related questions

Share this answer